BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9502329)

  • 1. The effects of alpha-tocopherol on critical cells in atherogenesis.
    Devaraj S; Jialal I
    Curr Opin Lipidol; 1998 Feb; 9(1):11-5. PubMed ID: 9502329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.
    Devaraj S; Li D; Jialal I
    J Clin Invest; 1996 Aug; 98(3):756-63. PubMed ID: 8698868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of monocyte-macrophage function with alpha-tocopherol: implications for atherosclerosis.
    Devaraj S; Harris A; Jialal I
    Nutr Rev; 2002 Jan; 60(1):8-14. PubMed ID: 11843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of alpha-tocopherol on monocyte proatherogenic activity.
    Jialal I; Devaraj S; Kaul N
    J Nutr; 2001 Feb; 131(2):389S-94S. PubMed ID: 11160567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein.
    Cachia O; Léger CL; Descomps B
    Atherosclerosis; 1998 Jun; 138(2):263-9. PubMed ID: 9690909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-tocopherol protects against monocyte Mac-1 (CD11b/CD18) expression and Mac-1-dependent adhesion to endothelial cells induced by oxidized low-density lipoprotein.
    Terasawa Y; Manabe H; Yoshida N; Uemura M; Sugimoto N; Naito Y; Yoshikawa T; Kondo M
    Biofactors; 2000; 11(4):221-33. PubMed ID: 11270503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by alpha- and gamma-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells.
    de Nigris F; Franconi F; Maida I; Palumbo G; Anania V; Napoli C
    Biochem Pharmacol; 2000 Jun; 59(11):1477-87. PubMed ID: 10751558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells.
    Ricciarelli R; Zingg JM; Azzi A
    Circulation; 2000 Jul; 102(1):82-7. PubMed ID: 10880419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E, oxidative stress, and inflammation.
    Singh U; Devaraj S; Jialal I
    Annu Rev Nutr; 2005; 25():151-74. PubMed ID: 16011463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atherosclerosis--the molecular background].
    Nilsson J
    Lakartidningen; 1991 Jan; 88(3):127-9. PubMed ID: 1999971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro.
    Martin A; Foxall T; Blumberg JB; Meydani M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):429-36. PubMed ID: 9102160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atherosclerosis. Description and mechanisms. Part 2: mechanisms].
    Capron L
    Rev Neurol (Paris); 1983; 139(4):239-50. PubMed ID: 6612139
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits.
    Bräsen JH; Koenig K; Bach H; Kontush A; Heinle H; Witting PK; Ylä-Herttuala S; Stocker R; Beisiegel U
    Atherosclerosis; 2002 Aug; 163(2):249-59. PubMed ID: 12052471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein modification: cellular mechanisms.
    Chait A; Heinecke JW
    Curr Opin Lipidol; 1994 Oct; 5(5):365-70. PubMed ID: 7858911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and atherogenesis.
    Stout RW
    Eur J Epidemiol; 1992 May; 8 Suppl 1():134-5. PubMed ID: 1505650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis.
    Upston JM; Terentis AC; Morris K; Keaney Jr JF; Stocker R
    Biochem J; 2002 May; 363(Pt 3):753-60. PubMed ID: 11964176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E).
    Carr AC; Zhu BZ; Frei B
    Circ Res; 2000 Sep; 87(5):349-54. PubMed ID: 10969031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering alpha-tocopherol to endothelial cells.
    Desrumaux C; Deckert V; Athias A; Masson D; Lizard G; Palleau V; Gambert P; Lagrost L
    FASEB J; 1999 May; 13(8):883-92. PubMed ID: 10224231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.